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Abstract The p53 protein is an important factor of many intra-
and extracellular processes. This protein regulates the repair of
cellular DNA and induces apoptosis. It is also responsible for
the regulation of the senescence and the cell entering the
subsequent stages of the cellular cycle. The protein p53 is also
involved in inhibiting angiogenesis and the induction of oxida-
tive shock. In our study, we examined the activity of p53
protein in the uterine epithelial cells in rats treated with
cladribine. Its action is mainly based on apoptosis induction.
We compared the activity of p53 protein in cells with a high
apoptosis index and in cells with active repair mechanisms and
high proliferation index. We observed stronger p53 protein
expression in the epithelial cells of the materials taken 24 h
after the last dose of 2-CdA associated with the active process
of apoptosis and inhibition of proliferation. After 4 weeks from
the last dose of cladribine, the stronger expression of p53
protein was associated with both the existing changes in the
cell's genome, the effects of the ongoing repair mechanisms, as
well as the high proliferation activity.
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Introduction
The p53 protein is a regulative factor of many processes
necessary for the proper functioning of cells, and it corre-
sponds to a number of processes associated with its life and
death. The p53 protein regulates the repair of cellular DNA
and induces apoptosis when the damage of the gene is too
serious and it is impossible to repair. This protein is also
responsible for the regulation of the senescence of cells and
the cell entering and leaving the subsequent stages of the
cellular cycle (in regard to the latter, the p53 protein can stop
the cellular cycle in checkpoints G1/S or G2/M in order to run
the repair mechanisms in the cell). What is more, the p53
protein can regulate intracellular processes directly or as result
of interactions with other proteins found within the cell
(Sznarkowska et al. 2010). It has also been demonstrated that
the p53 protein, as a result of stress factors, crosses into the
mitochondria and activates the expression of pro-apoptotic
genes, such as Puma , Bax , Apaf-1 , Noxa , as well as inhibits
the expression of anti-apoptotic genes, such as those of the
family Bcl-2 (Bcl-2 , Bcl-X , Bcl-in , Mcl-1 ). These pro-
apoptotic proteins, together with the p53 protein, are
transported into the mitochondria where they induce an in-
crease in the permeability of mitochondrial membranes and
the release of cytochrome c , which connects with the Apo-
ptotic protease activating factor 1 (Apaf-1) and with the
caspase 9 proenzyme, to create the complex called the
"apoptosome". The apoptosome, in turn, brings about caspase
9 activation, which consequently promotes the caspase 3
proenzyme to the active protease stage, which then adheres
to the group of effector caspase. These caspases are responsi-
ble for intracellular protein lysis as well as for the morpholog-
ical characteristic changes of apoptosis (Sznarkowska et al.
2010). What is more, the p53 protein participates in the
regulation of the apoptosis pathway, albeit dependent upon
the membranous death receptors, to regulate the height of the
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expression of gene coding receptors, such as FAS/APO1,
DR5/KILLER, and also the development of the ligand of the
FAS receptor (FasL). Furthermore, the promotion of the DR5
gene is indirectly activated by the p53 protein. Instead, the
expression of the FAS receptor on the cell's surface is en-
hanced by an increase in its transport from the Golgi apparatus
to the cell membrane (Takimoto and El-Deiry 2000). The
protein p53 is also involved in several other extracellular
processes, among them, in inhibiting angiogenesis and the
induction of oxidative shock. Under the right conditions, the
protein p53 is kept in a cell at a low level and in an inactive
form. During the course of the cell cycle, the level of this
protein is closely controlled by a number of different factors,
such as WT-1, MDM2, JNK, Pirh-2, PARP-1, and MDM4
protein (Pekova et al. 2011; Sznarkowska et al. 2010). How-
ever, in cells exposed to stress or exposed to factors damaging
the DNA, the half-life of p53 active protein forms can be
extended to several hours (Laptenko and Prives 2006), and
according to some research, the active form of the protein p53
is also observed in proliferating cells (Borner et al. 1997;
Mendoza-Rodríguez et al. 2002). In addition, in the last few
years, a novel role for p53 in neurobiology has emerged. This
includes a role in the regulation of neurite outgrowth and
axonal regeneration. What is more, the p53 protein probably
integrates a number of extracellular signals that involve
neurotrophins and axon guidance cues to modulate the cyto-
skeletal response associated with neurite outgrowth at both the
transcriptional and post-translational level (Di Giovanni and
Rathore 2012).
In our study, we examined the activity of p53 protein in the
epithelial cell of the uterine endometrium in female rats treated
with cladribine (2-chlorodeoxyadenosine [2-CdA]).
Cladribine represents a group of purine nucleoside analogues
that belong to drugs used in chemotherapy of many malig-
nances. Its action is mainly based on induction of apoptosis in
cells on the intrinsic pathway, which has been shown in
several studies (Klöpfer et al. 2004; Sznarkowska et al.
2010; Jędrych et al. 2013). The toxic effect of cladribine on
the epithelial cells of the uterus is transient, as confirmed by
analyzing the index proliferation of epithelial cells in different
time since cessation of 2-CdA administration. In this study, we
compared the activity of p53 protein in cells with a high index




White female Wistar rats were used for the study. These were
the 3- to 4-month-old females with an average body weight of
275 g. Cladribine (Biodribin manufactured by the Institute of
Biotechnology and Antibiotics in Warsaw) was applied sub-
cutaneously, interchangeably in the right and left side skin fold
at the site of the lumbar spine (the study was approved
by the Local Bioethics Commission of Medical University of
Lublin — number 126/2001). During the experiment, the
animals were housed in cages (one per cage) of a surface area
of 0.5 m2, with a preserved circadian cycle (12 h day, 12 h
night), air temperature around 21 °C and relative humidity
around 60 %. The rats received standard LSM feed and water
without limitations. Before starting the experiment, a cytolog-
ical smear of females was analyzed to determine the phase of
the estrous cycle of the studied females. In all the studied
females, the estrous cycle lasted 4 days and consisted of four
phases: proestrus, estrus, metestrus, diestrus. On the first day
of the fourth cycle, drug administration was begun.
Research groups
The animals were randomly placed into three groups: a control
group (C) and two study groups (A and B), each of which
consisted of five individuals. The animals in the study groups
were given the drug at a dose of 0.10 mg/kg BW/24 h, for 7
consecutive days, at exactly the same time. The dose
employed corresponded to the therapeutic dose used in the
treatment of proliferative disorders of the lymphatic system in
humans. The control group animals received only food and
water without limitations. In order to introduce a stress-
inducing factor as to that of the study groups, the rats in the
control group were administered physiological saline subcu-
taneously in a volume corresponding to the amount of drug
administered to rats in the study groups. Decapitation of
animals of both group A and control group was conducted
24 h after the last injection, i.e., on the fourth day of the cycle
(the final stage of diestrus). Decapitation of the animals in
study group B was conducted 4 weeks after the last injection.




After fixing the material in 10% buffered formalin, the organs
were embedded in paraffin blocks. The material was then
tailored into 5-μm-thick sections. The histomorphological
evaluation of tissues stained with hematoxylin and eosin
(H&E) was performed with the use of a light microscope
using objective 20, 40 and 100. Mitotic activity of uterine
epithelial cells we investigated by specifying cell mitotic
index (MI). In so doing, we took ten fields of vision with
objective 40, and analyzed 100 cells in each field of view.
After this, we calculated the number of mitotic figures among
the tested cells. The result was given as a percentage.
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Immunohistochemical tests
Immunohistochemical tests were then done using antibodies
directed against protein 53 (P5813; Sigma-Aldrich, St. Louis,
MO, USA; dilution 1:100), caspase 3 (WHO000836M2;
Sigma-Aldrich; dilution 1:50), and Antigen Ki-67 (HPA
000451; Sigma-Aldrich; dilution 1:100). The exposure of
the antigenic sites was performed thermally by incubation in
citrate buffer solution with pH = 6, in a microwave oven at
800 W, for 3 cycles lasting 5 min each. To inhibit endogenous
peroxidase activity, 0.3 % perhydrol (H202) in methanol was
used. Normal Serum was also used to block the nonspecific
bindings of antigen. The material was incubated in a primary
antibody diluted as recommended by the manufacturer over-
night at 4 °C. To visualize the reaction, diaminobenzidine
solution (DAB) and hematoxylin colouration were used. In
the negative control, experiments were conducted in a similar
manner, but omitted the specific primary antibody. The
material was evaluated with the use of a light micro-
scope using objective×20 and×40. The percentage of
cells with positive expression was calculated by counting
approximated 300 cells in at least three randomly chosen
microscopic fields (objective 40). Moreover, the intensity of
expression of individual proteins of uterus epithelial cells was
compared. The intensity was graded as low (+), intermediate
(++) and high (+++), by using the BX4 image analysis system
manufactured by Olympus, with a DP 25 digital camera
and the Cell^D software. In addition, the percentage of
cells of the given intensity expression in each analyzed
fields was calculated. These values were expressed as a
mean ± standard deviation. The obtained tests results
were subjected to statistical analysis with the use of Statistica
10.0 software StatSoft Polska. The chi-square (χ2) test was
applied to compare the mean of proteins indicating positive
and negative cells in groups. Furthermore, a statistical analysis
of the intensity of protein expression in groups was performed
with the use of Kruskal–Wallis test. In this regard, a probabil-
ity (p ) value less than 0.05 was considered statistically
significant.
Results
Histomorphological assessment of the uterus epithelium
in H&E staining
The uterus epithelium of the tested groups of animals in the
histomorphological study, showed no discernible pathological
changes under the light microscope at×40 objective (Fig. 1),
and the uterine cavity epithelium showed typical features for
female rats in the diestrus phase. In addition, the single layer
of columnar epithelium formed cells of low height, with oval
centrally located nuclei. Moreover, the chromatin in the major-
ity of cells represented heterochromatin. Furthermore, between
the epithelial cells, single lymphocytes appeared, while in the
uterine gland epithelium, quite a number of granulocytes were
evident.
What is more, in individual cells, we observed mitotic
divisions. These were visible in both the epithelial cell of the
uterine endometrium and the cells of the uterine glands
(Fig. 2). In ten fields of view under objective×40, the MI
was calculated. The median amounted to 1.5 % in the epithe-
lial cells of the control group and the experimental B group of
rats, while in the A experimental group epithelium, the median
of MI amounted to 0 % (Table 1).
Immunohistochemical evaluation
The p53 protein
In the epithelial cell of the uterine endometrium of female rats
treated with cladribine (A and B group), we observed the
intensive expression of p53 protein in the cell nuclei and in
the cytoplasm (Fig. 3). Moreover, a positive reaction was also
visible in most of the cells of this epithelium. However, the
intensity of the expression was varied, yet was consid-
erably higher in the experimental groups than in the
control group (Fig. 4). In addition, intensive expression
of p53 protein in epithelial cells of the uterine glands was also
observed.
Fig. 1 Section of the uterine epithelium.C control group,A study group A, B study group B; H&E staining. Typical epithelium in the diestrus stage. No
discernible pathological changes were observed
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We also demonstrated a significant difference in the occur-
rence of positive expression of p53 protein between the ex-
perimental groups and the control group, as well as the lack of
statistical difference in the expression of p53 protein occur-
rence between experimental groups A and B (Table 2). Fur-
thermore, the intensity of the p53 protein expression was
varied (Fig. 5): the strongest (+++) was found in group A
and the lowest in the control group (C).
The Ki-67 antigen
The expression of the Ki-67 antigen was also differentiated in
its dependence in each research group (Fig. 6). In our study,
we have shown a statistical difference in the occurrence of
antigen Ki-67 immunoprecipitations between experimental
and control groups, and between both experimental groups
(Table 2).
The lowest expression of the nuclear antigen Ki-67 in the
uterine epitheliumwas observed in experimental group A, and
in only about one third of the cells were we able to perceive a
positive immunohistochemical reaction (Fig. 4). In addition,
the positive precipitations that were observed both in the
epithelium covering the endometrium and in the epithelium
of uterine glands showed a low intensity of expression and
were assessed as 1 (+) (Fig. 5). Moreover, in experimental
group B, we observed significantly more cells containing
antigen Ki-67 positive immunoprecipitation, than in the uter-
ine epithelium sourced from animals in experimental group A.
Caspase 3
In the epithelium of the organs harvested from female rats 24 h
after exposure to cladribine (group A), caspase 3 expression
was also considerably more intensive than in the epithelium of
the uterus of animals decapitated 4 weeks later (group B), and
in the control group (Fig. 7).
Furthermore, the greatest number of positive immunopre-
cipitations was observed in experimental group A (65% of the
cells) and the least (35 %) in the control group (Fig. 4). The
intensity of the caspase 3 expression in uterine epithelium of
all groups was quite low (Fig. 5). We did not observe a high
expression (a rating of 3 [+++]) in any research group, while
the expression evaluated as 2 (++) appeared in only 4 % of the
cells of the material taken from group A, and 2 % of uterine
epithelial cells taken from group B, as well as 1 % of the
endometrial epithelial cells of the control group. A significant
difference in the occurrence of positive caspase 3 expression
was also observed between experimental groups and the con-
trol group, as well as between both experimental (A and B)
groups (Table 2).
Discussion
The proper functioning of the organism is dependent on the
presence of efficient mechanisms regulating the life processes
of each cell within it, and undoubtedly, the p53 protein plays a
primary role in regulating the multiple processes that occur
even at the organ level. This protein protects against the
reproduction of cells with the genome changes that result from
DNA damage, by stopping the cell cycle and inducing the
activation of cell repair mechanisms, as well as inducing cell
death. Research data also points to its involvement in the
inhibition of oncogenesis; hence, the gene TP53 is also called
the suppressor gene (Sznarkowska et al. 2010). Moreover, the
lack of active p53 protein brings about roughly 50 % of the
mutation of the TP53 gene and is the basis of the origin of
many cancers (Karagece Yalçin and Seçkın 2012). It is also
Fig. 2 Section of the uterine
epithelium. C control group
(×1,000), B study group B
(×400), with mitotic figures
(arrows). H&E staining. A
number mitotic figures were
seen in groups C and B
(median = 1.5 %); in group A,
these were very rarely observed
(median = 0)
Table 1 Mitotic Index in uterine
epithelium Mitotic index in uterine epithelium Group A Group B Control group
MI MI MI
Median 0 1,5 % 1,5 %
Mean±standard deviation (SD) 0.5±0.849837 % 1.5±1.080123 % 1.6±0.966092 %
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been documented that p53 protein is involved in the differen-
tiation of stem cells, as well as in the reprogramming of
somatic cells (Yi et al. 2012).
In our work, we investigated the expression of the p53
protein in uterine epithelium with active apoptosis (group A)
and active proliferation (group B). Apoptosis was induced by
the purine nucleoside analogue drug, cladribine.We compared
the expression of p53 protein in tissues collected 24 h after last
injection with cladribine (group A), in which the process of
apoptosis was bolstered, with the expression in tissue taken
4 weeks after cessation of the cladribine supply, which
showed active proliferation. By way of immunohistochemical
tests, we assessed the expression of p53 protein, while also
assessing the effector caspase 3, by way of the molecular
apoptosis marker and the nuclear antigen Ki-67, through the
proliferation indicator (Chmielewski et al. 2008; Klöpfer et al.
2004; Sznarkowska et al. 2010; Gerdes et al. 1984). The
research material was taken in the diestrus phase of estrus
cycle, in which sex hormones do not have great involvement
due to their low level (Marcondes et al. 2002).
Normally, the physiologically two-horned uterus of the
female rat in the early phases of diestrus is not large and is
scantily vascularized. Moreover, the uterus is slightly lined by
low columnar epithelium containing single degenerating
(apoptotic) cells. In the course of several hours, all the cells
of the endometrium will have had surrendered to mitotic
divisions. Following this, glands resume the secretion activity,
and the epithelial cells of these glands intensely proliferate.
Subsequently, gradual growth of the blood supply and the
swelling of endometrium comes about (Westwood 2008).
In our work, the analyzed histomorphological view of the
uterine epithelium of the examined animals showed this cor-
rect construction and sequencing. In addition, among the
epithelial cells were many ciliated cells. Furthermore, the
cytoplasm of these cells were weakly coloured with the acid
stain (showing up as being brightly pink in colour), while the
nuclei of the majority of cells were coloured with the basic
stain (showing up as brightly navy blue coloured). Inside the
nuclei, the nucleoli were evident. In the epithelium of the
uterus we observed small cells undergoing mitotic divisions.
This is typical for the epithelium of genital organs of the
female rat in the diestrus phase (Sato et al. 1997; Westwood
2008). By comparing the histomorphological view of the
uterine epithelium of the investigative groups of female rats,
we observed a greater frequency of the occurrence of mitotic
figures in experimental group B and in the control group
(median of IM = 1.5 %), than in experimental group A
(median IM = 0 %).
Fig. 3 Expression of 53 protein in uterine epithelial cells.C control group,A study group A,B study group B. The higher expression is seen in groups A
and B
Fig. 4 Percentage of positive
expression in uterine epithelial
cells. Positive expression of p53
protein and caspase 3 was
observed more frequently in
experimental groupsA and B than
in the control group. Positive
expression of Ki-67 antigen was
rarely observed in group A
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For the confirmation of the cell proliferative activity, we
undertook immunohistochemical tests of the nuclear Ki-67
antigen expression (which is acknowledged as the primary
marker of cell proliferation (Gerdes et al. 1984)). This protein
occurs in the cell nucleus, during cell division, and is present
on the chromosomes. A positive expression of the Ki-67
antigen in the cell occurs in phases of S, G2 and M of the cell
cycle and in G1 following the mitotic division. The lack of
expression of Ki-67 antigen is observed only in rest cells in the
G0 phase (Gerdes et al. 1984; Muskhelishvili et al. 2003). In
our study, the expression of nuclear Ki-67 antigen was the
lowest among the uterine epithelial cells of animals of exper-
imental group A (positive in 33 % of the cells), whereas in the
epithelium of animals in experimental group B, expression of
the antigen was higher (and positive in about 70 % of the
uterine epithelial cells). In regard to the uterine epithelium of
the animals of the control group, this showed far beyond that
found in groups A and B, a positive expression of the Ki-67
antigen (88 % of the epithelial cells of the uterus). The
presence of differences in the expression of this proliferation
marker — as revealed through the immunohistochemical
method in the individual research groups — confirmed the
results of the MI analysis in the H&E staining. A positive
expression of this antigen was observed in the considerably
greater percentage of cells than that during IM. This is
connected with the presence of this antigen not only during
mitotic division, but also in other active phases of the cell
cycle. Hence, it is possible to score a greater number of cells
by the use of immunohistochemical tests (Gerdes et al. 1984).
For the purpose of ascertaining the qualifications of the
quantity of apoptotic cells found in the epithelium of the
examined organs, we undertook an investigation of the
caspase 3 expression by the immunohistochemical method.
Caspase 3 is one of the more important executive caspases in
the apoptosis process, as it is directly involved in the break-up
of intracellular structures that lead to the formation of apopto-
tic bodies. Thus, a measurement of its activity is used to
evaluate the intensification of this process in the cells
(Chmielewski et al. 2008). The p53 protein also plays a crucial
role in the process of cladribine-induced apoptosis, which was
confirmed by several studies (Klöpfer et al. 2004;
Sznarkowska et al. 2010; Jędrych et al. 2013; Wawryk-
Gawda et al. 2011). In our study, we observed a high expres-
sion of p53 protein in experimental group A. In the tissue of










p53 protein p=0.2538 p <0.0001 p <0.0001
Caspase 3 p=0.0002 p <0.0001 p =0.0001
Antigen Ki-67 p<0.0001 p <0.0001 p <0.0001
Fig. 5 The expression of p53 protein, antigen Ki-67 and caspase 3 of
defined intensity in particular research groups. The higher expression of
p53 protein was seen in groups A and B. The expression of caspase 3 was
highest in group A, lower in group B, and lowest in the control group. The
expression of antigen Ki-67 was lowest in group A, and higher in group B
and the control group
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this group, as much as 90 % of the cells showed a positive
expression (Fig. 4). Moreover, a high reaction, assessed as 3
(+++), were observed in 10 % of the epithelial cells of the
endometrium (Fig. 5), while 25 % of the epithelial cells lining
the cavity of the uterus expression were evaluated as 2 (++). In
addition, in the epithelial cell of the uterine endometrium of
female rats decapitated 4 weeks after the end of chemotherapy
we observed the intense reaction of the p53 protein. In this
group, a positive response directed against the p53 protein was
found within about 92 % of the epithelial cells of the endo-
metrium. Furthermore, a high response (+++) was observed in
approximately 5 % of the epithelial cells of the uterus. How-
ever, statistical analysis of the obtained results showed that the
difference in the expression of p53 protein intensity in the
cells of the epithelium after 4 weeks from the last dose of
cladribine in respect to group B (decapitated 24 h after the last
2-CdA application) was not statistically significant (p >0.05,
Table 2). Moreover, the intensity of this protein expression
was significantly lower in the epithelium of the control group
(p <0.0001).
To interpret the obtained results, we should note the evi-
dence of p53 protein precipitations in the cellular nuclei cell
results from the presence of the active form of this protein. In
cells not subjected to any stress, p53 protein is inactive and its
positive expression as detected by immunohistochemical
methods, physiologically can occur only in the cytoplasm.
However, the presence of nuclear p53 protein expression
indicates need for the mobilization of the intracellular repair
processes dependent on the p53 protein (Sznarkowska et al.
2010; Liu and Kulecz-Martin 2001). Furthermore, an increase
in the intensity of expression of this protein is associated with
its enhanced concentration in the cell, which in turn is associ-
ated with greater damage occurring in the cell. According to
Sznarkowska et al. (2010), arrest of the cell cycle and the
DNA damage repair require less active p53 protein concen-
tration, while apoptotic induction is necessary for it to have a
greater level in the cell.
From our data (discussed above) and observations, it can be
concluded that the enhanced intensity of growth protein p53
expression in the epithelium of animals in the experimental
groups can be triggered by actions resulting from cladribine
DNA damage. This is in concordance with previous research
in that a similar increase in the expression of p53 protein was
observed in several studies of the lymphoid cells treated with
cladribine (De Viron et al. 2009; Johnston 2011; Nocentini
1996). In addition, the presence of active forms of the protein
p53 and caspase 3 in the cell at the same time is due to the
existence of certain changes with which cells can no longer
function properly. Such cells are then eliminated from the
body by way of programmed death (Korzeniewska-Dyl
2007; Sznarkowska et al. 2010).
In our research, the most intense caspase 3 expression
within the sampled uterine epithelial cells was in experimental
group A. In these tissues, 65 % of uterine epithelial cells
showed a positive expression of caspase 3, while in experi-
mental group B, positive precipitations were observed in 50%
Fig. 6 Expression of antigen Ki-67 in uterus epithelial cells. C control group, A study group A, B study group B. The higher expression was found in
group B and the control group
Fig. 7 Expression of caspase 3 in uterus epithelial cells. C control group, A study group A, B study group B
P53 protein in proliferation, repair and apoptosis of cells 531
of epithelial cells of the uterus (Fig. 4). Coefficients of signif-
icant dependence among caspase 3 expression in these groups,
in all of the tests, were statistically significant (p <0.05). These
results were the same between the experimental groups and
the control group (Table 2). In the control group, the positive
immunohistochemical reaction of caspase 3 was observed in
35 % of the epithelial cells of the uterus.
The positive precipitations observed in epithelium of ani-
mals receiving only saline injections indicate the presence of
single apoptotic cells in these organs, which is physiologically
normal during this estrous cycle phase in female rats (Sato
et al. 1997; Westwood 2008). However, the more intensive
reactions both p53 proteins and caspase 3 in the epithelium of
group B rats, as compared with the control group, according to
previously described data, may indicate that, in parts of the
cells of the epithelium, the changes in the genetic material
induced by cladribine were so significant that the ongoing
repair mechanisms in these cells had been overwhelmed. They
are therefore directed towards the programmatic death path-
way with the assistance of the p53 protein.
When considering the reasons for the strong expression of
p53 protein in the cells of the epithelium, one should keep in
mind the other processes regulated by this protein. In addition
to the described damage of the genome, the directly activated
p53protein observed in groups receiving cladribine may also
lead to the intensification of the regenerative processes
(Sznarkowska et al. 2010). Hence, an increase in the intracel-
lular activity of p53 protein in group B may therefore be
associated with the higher proliferation process of this epithe-
lium (Borner et al. 1997; Mendoza-Rodríguez et al. 2002).
This, again, is in line with previous studies. In Borner et al.'s
(1997) study, a growth of p53 protein activity was observed in
both human peripheral blood mononuclear cells (PBMC),
which were treated with cladribine (which showed similar
characteristics within the apoptotic cells), and in cells induced
to proliferate through the mitogen phytohemagglutinin
(PHA). However, in a study of Mendoza-Rodriguez et al.,
the increased expression of both p53 mRNA and p53 proteins
within the epithelial cells of the endometrium at the metestrus
phase was associated with increased proliferation activity of
these cells. Furthermore, Mendoza-Rodríguez et al. (2002)
found that, while in the estrus phase (when the number of
apoptotic cells increases), this expression was at the lowest
level.
To summarize, in our study, the stronger p53 protein ex-
pression in the epithelial cells of experimental group A, and at
the same time, the lowest expression of nuclear antigen Ki-67
observed in this group was associated with the active process
of apoptosis and inhibition of proliferation. Four weeks after
the last dose of cladribine (group B), the stronger expression
of p53 protein (compared with the control group) is likely
associated with the existing changes in the cell's genome, the
effects of the ongoing repair mechanisms, as well as the
greater proliferation activity (as compared to experimental
group A), as evidenced by the stronger expression of the Ki-
67 nuclear antigen in this group.
Conclusions
The p53 protein takes an active part in the process of apoptosis
that is induced by cladribine and by cellular proliferation, and
this leads to organ regeneration.
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